# Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain

> **NCT02084511** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 80 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Placebo to BI 1026706 solution
- **DRUG:** BI 1026706
- **DRUG:** Placebo to BI 1026706 tablet
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT02084511
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084511, "Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02084511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*